Market Overview

Endo Health Solutions to Buy Boca Pharmacal for $225M

Share:
Related ENDP
Earnings Scheduled For March 2, 2015
Benzinga's M&A Chatter for Tuesday February 24, 2015
Endo beats by $0.04, beats on revenue (Seeking Alpha)

Endo Health Solutions (NASDAQ: ENDP) today announced that its Qualitest subsidiary has reached a definitive agreement to acquire privately held Boca Pharmacal, a specialty generics company, for $225 million in cash.  The transaction is expected to enhance the growth platform and pipeline for Endo's Qualitest business and is consistent with Endo's strategic transformation into a leading specialty healthcare company.

Posted-In: News M&A

 

Related Articles (ENDP)

Around the Web, We're Loving...

Get Benzinga's Newsletters